Related Experiment Video
Updated: Jun 12, 2026
06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Cobalamin deficiency, hyperhomocysteinemia, and dementia
1Kansas University School of Medicine - Wichita, Wichita, KS, USA. drwerder@chcsek.org
Neuropsychiatric Disease and Treatment
|May 28, 2010
Summary
High homocysteine levels, with or without low vitamin B12, are a risk factor for dementia. Testing and treating vitamin B12 deficiency, especially with pernicious anemia, is crucial for cognitive health.
Area of Science:
- Neurology
- Nutritional Science
- Geriatrics
Background:
- Clinical guidelines recommend serum vitamin B12 testing for dementia patients.
- Clinicians face challenges in patient selection, test interpretation, and treatment efficacy for vitamin B12 deficiency in dementia.
- The relationship between vitamin B12 deficiency, hyperhomocysteinemia, and dementia requires clarification.
Purpose of the Study:
- To address key clinical questions regarding the evaluation and management of vitamin B12 deficiency in dementia.
- To clarify the role of vitamin B12 and hyperhomocysteinemia as risk factors for dementia.
- To provide evidence-based recommendations for diagnosing and treating vitamin B12 deficiency in patients with cognitive impairment.
Main Methods:
- A comprehensive Medline search was conducted on January 31st, 2009, focusing on cobalamin deficiency, hyperhomocysteinemia, and dementia.
- 1,627 citations were retrieved and categorized into six major groups: general, biochemistry, manifestations, associations and risks, evaluation, and treatment.
- Seventy-five key studies, series, and clinical trials were identified and reviewed to answer specific clinical questions.
Main Results:
- Hyperhomocysteinemia, with or without low vitamin B12, is a convincing risk factor for dementia.
- Low vitamin B12 without hyperhomocysteinemia is less convincingly linked to dementia risk.
- Vitamin B12 deficiency presents with variable psychiatric, neurological, gastrointestinal, and hematological findings; leukoaraiosis is common in hyperhomocysteinemia.
Conclusions:
- Serum B12 testing is crucial for suspected pernicious anemia and may benefit mild cognitive impairment or mild-to-moderate dementia.
- Standard initial testing includes serum B12 (≤200 pg/mL is low, 201-350 pg/mL is borderline); further tests like plasma homocysteine and MMA may be indicated.
- Dementia of the Alzheimer's type is compatible with B12 deficiency, except when caused by pernicious anemia. Treatment response varies, with oral cyanocobalamin often favored.
Related Concept Videos
01:30Vitamins
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.